Aptus Biosciences LLC
Gainesville, FL
- UEI
- P69KB94KHH28
- CAGE
- 98HN7
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Partnership or Limited Liability Partnership
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 2734 NW 136th Terrace, Gainesville, FL 32606, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Rapid affordable aptamer-based diagnostic test for hepatitis c virus | Office of Financial Resources | $1,002,400 | |
| Sepsis diagnosis using chemically modified DNA aptamers - summary sepsis is a condition in which severe infections are… | National Institute of General Medical Sciences | $356,500 | |
| Diagnostic aptamer reagents to develop multi-analyte blood test for pre-clinical, mild and moderate alzheimer's… | National Institute on Aging | $891,108 |
About Aptus Biosciences LLC
Aptus Biosciences LLC is a minority-owned small business located in Gainesville, Florida, specializing in advanced diagnostic research and development with a focus on innovative aptamer-based technologies. Registered in SAM.gov since January 2022, the company is structured as a limited liability company and is classified as a self-certified small disadvantaged business with a subcontinent Asian-Indian ownership. The organization leverages sophisticated molecular diagnostic technologies to develop cutting-edge diagnostic solutions for complex medical conditions, utilizing unique aptamer selection and modification techniques to create highly sensitive and specific diagnostic reagents.
Through federal grant awards, Aptus Biosciences LLC has secured significant funding from multiple National Institutes of Health (NIH) agencies to develop advanced diagnostic tests for critical medical conditions. The company has received project grants from the National Institute of General Medical Sciences (NIGMS) to develop chemically modified DNA aptamers for sepsis diagnosis, from the Centers for Disease Control and Prevention (CDC) to create a rapid diagnostic test for Hepatitis C virus, and from the National Institute on Aging to develop multi-analyte blood test reagents for pre-clinical, mild, and moderate Alzheimer's disease. These grants, totaling approximately $857,700, demonstrate the company's expertise in creating innovative diagnostic technologies that address significant global health challenges. The research focuses on developing rapid, affordable diagnostic tools that can improve early detection and management of complex medical conditions by creating highly sensitive aptamer-based testing methodologies.
Quick answers
What is Aptus Biosciences LLC's UEI?
Aptus Biosciences LLC's Unique Entity ID (UEI) in SAM.gov is P69KB94KHH28.
What is Aptus Biosciences LLC's CAGE code?
Aptus Biosciences LLC's CAGE code is 98HN7.
What is Aptus Biosciences LLC's primary NAICS code?
Aptus Biosciences LLC's primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Where is Aptus Biosciences LLC located?
Aptus Biosciences LLC's physical address in SAM.gov is 2734 NW 136th Terrace, Gainesville, FL 32606, USA.
Is Aptus Biosciences LLC registered in SAM.gov?
Aptus Biosciences LLC's SAM.gov registration expired on September 30, 2026.
What is Aptus Biosciences LLC's most recent federal award?
Aptus Biosciences LLC's most recent federal grant award is Rapid affordable aptamer-based diagnostic test for hepatitis c virus (R43PS005315), from Office of Financial Resources, on September 30, 2025.
On GovTribe
See Aptus Biosciences LLC's full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors